NCT03872817 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M
Developing and evaluating complex interventions: the new Medical Research Council guidance. Int J Nurs Stud. 2013 May;50(5):587-92. doi: 10.1016/j.ijnurstu.2012.09.010. Epub 2012 Nov 15.
Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P
"Mental health literacy": a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Med J Aust. 1997 Feb 17;166(4):182-6.
Jorm AF
Improving the mental health of the population: where to next? Med J Aust. 2014 Jul 7;201(1):23-4.
Jorm AF
Mental health literacy. Public knowledge and beliefs about mental disorders. Br J Psychiatry. 2000 Nov;177:396-401. Review.
Jorm AF
Mental health literacy: empowering the community to take action for better mental health. Am Psychol. 2012 Apr;67(3):231-43. doi: 10.1037/a0025957. Epub 2011 Oct 31.
Loureiro LM
Questionnaire for Assessment of Mental Health Literacy - QuALiSMental: study of psychometric properties. Revista de Enfermagem Referência serIV(4): 79-88, 2015. https://dx.doi.org/10.12707/RIV14031

Development and Piloting of a Psychoeducational Intervention to Promote Mental Health Literacy in Adolescents in a School Context

Clinical trial NCT03872817 - References